Farhana B. Lockhat

No ORCID on file · 6 papers in corpus · active 2002-2005

Study types

  • article 5
  • other 1

Condition tags

  • endometriosis 6
  • dysmenorrhea 1
  • chronic_pelvic_pain 1
other 2005
Fertility and Sterility ·doi:10.1016/j.fertnstert.2004.07.961

OBJECTIVE: To determine and compare levels of levonorgestrel (Lng) in serum and peritoneal fluid (PF) of patients on the Lng intrauterine system Mirena (Schering Health, Berlin, Germany) for endometriosis and to relate these to symptoms. D…

article 2005
·doi:10.1097/01.ogx.0000167406.63373.53

Most treatments used to date for endometriosis cause systemic side effects that not only may reduce compliance, but also preclude their long-term use. The levonorgestrel intrauterine system, which delivers the progestogen levonorgestrel dir…

article 2004
Human Reproduction ·doi:10.1093/humrep/deh650

BACKGROUND: Side-effects and choice of drugs influence compliance during treatment for endometriosis. Progestogen administered by a device with a 5-year lifespan, has been shown to be an effective medical alternative with several advantages…

article 2003
Human Reproduction ·doi:10.1093/humrep/deh004

BACKGROUND: Medical treatment of endometriosis, a condition which significantly affects the quality of life in approximately 10-15% of women in the reproductive years, remains problematic. Although oral progestogens are effective and cheap,…

article 2002
·doi:10.1016/s0015-0282(01)03086-2
article 2002
·doi:10.1016/s0015-0282(01)03116-8